Company / Revenue per Share
Boston Scientific Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$13.43
FY2025
5-year range
$7.61 / $13.43
FY2021-FY2025
Trend
+19.2%
vs FY2024
Sector context
#106 of 153
Health Care
What the data says
At $13.43, Boston Scientific's revenue per share ranks #106 of 153 in the Health Care sector. Revenue per Share has increased for 5 consecutive years, from $7.01 in FY2020 to $13.43 in FY2025.
Based on SEC 10-K filings.
13.43 in FY2025 with a 5-year CAGR of +13.9%.
Improved from $9.93 to $13.43 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Sector benchmark
#106 of 153 in Health CareTop 69% of 153This company $13.43 Sector average $124.28
▼
-89.2% below sector average
Key checks
Key Insights
- Boston Scientific's revenue per share has grown for 5 consecutive years.
- In FY2025, revenue per share increased 19.2% year-over-year.
- Ranks #106 out of 153 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.43 | +19.2% |
| FY2024 | $11.27 | +13.5% |
| FY2023 | $9.93 | +12.7% |
| FY2022 | $8.81 | +15.7% |
| FY2021 | $7.61 | +8.6% |
| FY2020 | $7.01 | -8.9% |
| FY2019 | $7.70 | +8.5% |
| FY2018 | $7.09 | +7.7% |
| FY2017 | $6.59 | -2.3% |
| FY2016 | $6.74 | +10.9% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026